Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Supha PharmachemBOM:539561 -3.13%54 Current Ratio is 1.07 as of Sep. 2025, which is 26% below its 10-year median of 1.44. GuruFocus rates BOM:539561 with a GF Score™ of 54/100 and a GF Value™ of ₹1.52 (Possible Value Trap). The stock has 12 warning signs investors should review. Among 1,000 Drug Manufacturers companies, Supha Pharmachem ranks worse than 80.8% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Supha Pharmachem's current ratio for the quarter that ended in Sep. 2025 was 1.07.
Supha Pharmachem has a current ratio of 1.07. It generally indicates good short-term financial strength.
The historical rank and industry rank for Supha Pharmachem's Current Ratio or its related term are showing as below:
BOM:539561'
s Current Ratio Range Over the Past 10 Years
Min: 1.01 Med: 1.44 Max: 294.16
Current: 1.07
During the past 11 years, Supha Pharmachem's highest Current Ratio was 294.16. The lowest was 1.01. And the median was 1.44.
BOM:539561's Current Ratio is ranked worse than 80.8% of 1000
companies
in the Drug Manufacturers industry
Industry Median: 2
vs BOM:539561: 1.07
Supha Pharmachem (BOM:539561) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Supha Pharmachem Current Ratio Related Terms
Supha Pharmachem Current Ratio Historical Data
* Premium members only.
The historical data trend for Supha Pharmachem's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Supha Pharmachem's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Supha Pharmachem Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Supha Pharmachem's Current Ratio distribution charts can be found below:
* The bar in red indicates where Supha Pharmachem's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Supha Pharmachem (BOM:539561) has a Current Ratio of 1.07 as of Sep. 2025. This is 26% below median its historical median of 1.44. Over the past decade, Supha Pharmachem's Current Ratio has ranged from 1.01 to 294.16. According to the industry distribution chart, Supha Pharmachem ranks #808 out of 1000 companies in the Drug Manufacturers industry, placing it in the top 80.8%.
Is Supha Pharmachem's Current Ratio too high?
Supha Pharmachem's current Current Ratio of 1.07 is 26% below median its 10-year median of 1.44. Over the past 10 years, this metric has ranged from a low of 1.01 to a high of 294.16. The Drug Manufacturers industry median Current Ratio is 2.00. Supha Pharmachem's value of 1.07 is 46.5% below this industry median. Based on the distribution chart, Supha Pharmachem ranks #808 out of 1000 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Supha Pharmachem has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Supha Pharmachem's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Supha Pharmachem ranks #808 out of 1000 companies for Current Ratio. This places Supha Pharmachem in the lower half of its industry. The industry median Current Ratio is 2.00. Supha Pharmachem's value of 1.07 is 46.5% below this benchmark. Historically, Supha Pharmachem's own Current Ratio has ranged from 1.01 to 294.16 over the past decade. While the company's 10-year median is 1.44 vs. the industry median of 2.00, Supha Pharmachem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 1,000 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Supha Pharmachem's current Current Ratio of 1.07 is 46.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Supha Pharmachem's current Current Ratio is 1.07, which is 26% below median its own 10-year median of 1.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supha Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Supha Pharmachem (BOM:539561) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1.52, compared to a current price of ₹0.31 — trading 79.6% below its estimated fair value. The current Current Ratio is 1.07, which is 26% below median its 10-year median of 1.44 and 46.5% below the Drug Manufacturers industry median of 2.00. Supha Pharmachem's overall GF Score™ is 54/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Supha Pharmachem (BOM:539561), the current Current Ratio is 1.07 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Supha Pharmachem (BOM:539561) Overvalued in 2026?
Based on GuruFocus' analysis, Supha Pharmachem stock appears to be undervalued.
The current stock price of ₹0.31 is trading 79.6% below its estimated GF Value™ of ₹1.52.
GuruFocus considers Supha Pharmachem to be Possible Value Trap.
Key valuation signals for BOM:539561:
Current Ratio: 1.07 (26% below median its 10-year median of 1.44)
GF Value™: ₹1.52 vs. price of ₹0.31 (79.6% below fair value)
Industry Position: 46.5% below the Drug Manufacturers median (#808 of 1000)
No single metric tells the full story. See the BOM:539561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Supha Pharmachem Ltd, formerly known as Remedium Lifecare Ltd, is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).
54GF Score
Get the complete analysis for BOM:539561
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:539561 has been successfully added to your 
